Insider · CIK 0001031686
Mir A Imran
Files at RANI (Rani Therapeutics Holdings, Inc.). First filing Oct 27, 2025, latest Oct 27, 2025.
Mir A Imran files SEC Form 4 as director and 10% owner at RANI (Rani Therapeutics Holdings, Inc.). Since Oct 27, 2025, Mir A Imran has reported 1 open-market buy worth $1.3M and 0 open-market sells worth $0, the latest filed on Oct 27, 2025.
A track record needs three past buys with six months of prices behind them; Mir A Imran has 0, so none is measured yet.
The newest scored trade: bought $1.3M of RANI on Oct 23, 2025, filed Oct 27, 2025, scored 52 (moderate). In the last 12 months: 1 buy worth $1.3M and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RANI: Rani Therapeutics Holdings, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 52Moderate | RANIbuy Rani Therapeutics Holdings, Inc. | $1.3M 2,083,334 shares | - | +410% from low-27% from high |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 28, 2026 | RANI Rani Therapeutics Holdings, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +123,600 | $0.00 | $0 | 123,600 | Jun 1, 2026 |
| Oct 23, 2025 | RANI Rani Therapeutics Holdings, Inc. | POpen-market purchase Class A Common Stock | +2,083,334 | $0.61 | $1.3M | 2,083,334 | Oct 27, 2025 |
| Oct 23, 2025 | RANI Rani Therapeutics Holdings, Inc. | POpen-market purchase Warrant to Purchase Class A Common Stockderivative | +2,083,334 | $0.00 | $0 | 2,083,334 | Oct 27, 2025 |
| May 28, 2025 | RANI Rani Therapeutics Holdings, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 30, 2025 |
| Dec 16, 2024 | RANI Rani Therapeutics Holdings, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -101,276 | - | - | 0 | Dec 17, 2024 |
| Dec 16, 2024 | RANI Rani Therapeutics Holdings, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +101,276 | - | - | 101,276 | Dec 17, 2024 |
Questions about Mir A Imran
Answered from the filings on this page, as of the latest one.
Is Mir A Imran buying or selling?
In the last 12 months Mir A Imran reported 1 open-market buy worth $1.3M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $1.3M of RANI on Oct 23, 2025. Grants, option exercises and tax withholding are not counted.
How did Mir A Imran's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mir A Imran has 0.
Where does Mir A Imran file Form 4?
Mir A Imran has filed Form 4 at RANI (Rani Therapeutics Holdings, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.